ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Rictor mTORC2 Signaling Protects Ischemic Liver Injury by Targeting Both Liver Parenchymal and Non-Parenchymal Cells

H. Zhou,1 Z. Rao,1 R. Liu,1 S. Zhou,1 J. Rao,1 J. Gu,1 H. Lu,1 Y. Xia,1 X. Wang,1 Y. Zhai,2 L. Lu.1

1First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2David Geffen School of Medicine at University of California-Los Angeles, Los Angeles.

Meeting: 2018 American Transplant Congress

Abstract number: A60

Keywords: Hepatocytes, Inflammation, Ischemia, Liver transplantation

Session Information

Session Name: Poster Session A: Innate Immunity; Chemokines, Cytokines, Complement

Session Type: Poster Session

Date: Saturday, June 2, 2018

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Background and Aims:Mammalian target of rapamycin (mTOR) signaling controls many essential cellular functions. However, the role and its underlying mechanism of Rictor/mTOR complex 2 (mTORC2) in regulating liver ischemia and reperfusion (IR) injury remains largely unknown.

Methods: In a murine liver partial warm IR model, we selectively knockdown Rictor signaling in liver parenchymal and non-parenchymal cells. Hepatocellular injury and Kupffer cell (KC) pro-inflammatory activation were studied. Rictor signaling in human liver tissues post ischemia was also analyzed.

Results: Liver ischemia triggered a transient inactivation followed by a rapid reactivation during reperfusion. Abrogation of mTORC2 signaling in hepatocytes by Rictor-shRNA-AAV8 resulted in significantly increased liver IR injury. In vitro, knockdown of Rictor in hepatocyte inhibited hepatocellular autophagy, enhanced CHOP and pro-apoptosis signaling pathway activation, leading to increased TNF-a induced cell death. Furthermore, Rictor siRNA with mannose-conjugated polymers was used to specifically block Rictor signaling in KC. KCs post IR were isolated and inflammatory cytokine secretion was evaluated. Specific Rictor knockdown in KC resulted in significant increase in TNF-α and IL-6 secretion but dramatically decreased anti-inflammatory IL-10 secretion. Interestingly, autophagy in KC was inhibited by Rictor knockdown as well. We further analyzed the role of Rictor in KC M1/M2 polarization. Rictor knockdown inhibited IL-10-secreting M2-like macrophage polarization, as revealed by decreased Arg1 and Mrc1 gene induction accompanied by a decrease in STAT6 signaling pathway activation. In vivo Rictor knockdown decreased intrahepatic anti-inflammatory IL-10 gene induction, leading to aggravated liver IR injury. Finally, human liver tissues were collected in patients undergoing liver partial resection with blockade of hepatic portal. Western blot analysis revealed that Rictor activation was inhibited by liver ischemia.

Conclusion: Our findings defined a critical role of mTORC2 signaling in protecting livers against IR injury by promoting hepatocellular autophagy and facilitating KC M2 polarization. Targeting Rictor signaling pathway may shine light on ways to protect against liver ischemic injury in patients.

CITATION INFORMATION: Zhou H., Rao Z., Liu R., Zhou S., Rao J., Gu J., Lu H., Xia Y., Wang X., Zhai Y., Lu L. Rictor mTORC2 Signaling Protects Ischemic Liver Injury by Targeting Both Liver Parenchymal and Non-Parenchymal Cells Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Zhou H, Rao Z, Liu R, Zhou S, Rao J, Gu J, Lu H, Xia Y, Wang X, Zhai Y, Lu L. Rictor mTORC2 Signaling Protects Ischemic Liver Injury by Targeting Both Liver Parenchymal and Non-Parenchymal Cells [abstract]. https://atcmeetingabstracts.com/abstract/rictor-mtorc2-signaling-protects-ischemic-liver-injury-by-targeting-both-liver-parenchymal-and-non-parenchymal-cells/. Accessed May 13, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences